CERS
CERUS CORP
NASDAQ · Healthcare · Medical - Devices · US
$2.29
−6.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 93.00x
- P/S forward
- 1.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.58x
- Price / sales
- 2.08x
- Price / cash flow
- 190.52x
Enterprise value
- Enterprise value
- $481.7M
- EV / sales
- 2.17x
- EV / EBITDA
- 165.65x
- EV / EBIT
- -297.90x
- Market cap
- $460.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026